Metraipolis › archive › dc_d18c7d9eda35
Leveraging network pharmacology in the treatment of asthma — Europe PMC PMID:42633488
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42633488
- DOI
- 10.5599/admet.3281
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T11:43:03.739Z
- SHA-256 of the archived text
f3108f70941aa1dee4a39fd167246938fc230a5c46489486478f1a154f321e8e- Stable URL of this page
https://metraipolis.com/documento/dc_d18c7d9eda35
How to cite
Leveraging network pharmacology in the treatment of asthma — Europe PMC PMID:42633488 — Europe PMC (en), https://europepmc.org/article/MED/42633488 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d18c7d9eda35 (Metraipolis archive dc_d18c7d9eda35, sha256 f3108f70941aa1dee4a39fd167246938fc230a5c46489486478f1a154f321e8e)
BibTeX
@misc{dcd18c7d9eda35,
title = {Leveraging network pharmacology in the treatment of asthma — Europe PMC PMID:42633488},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42633488},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d18c7d9eda35; sha256 f3108f70941aa1dee4a39fd167246938fc230a5c46489486478f1a154f321e8e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42633488. Agents can read the archived copy with the MCP tool read_document.